Cargando…

Administration of glycyrrhetinic acid reinforces therapeutic effects of mesenchymal stem cell‐derived exosome against acute liver ischemia‐reperfusion injury

Recent studies have shown that mesenchymal stem cell‐derived exosome could attenuate ischaemia‐reperfusion (I/R) injury by suppressing inflammatory response in the liver. Glycyrrhetinic acid was also shown to be capable of repressing the TLR4 signalling pathway. However, it remains to be explored as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Xiaolin, Zheng, Wenjing, Tian, Peikai, Liu, Hui, He, Yong, Peng, Minjie, Liu, Xiangde, Li, Xiaowu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576231/ https://www.ncbi.nlm.nih.gov/pubmed/32902129 http://dx.doi.org/10.1111/jcmm.15675

Ejemplares similares

The Protective Effects of Glycyrrhetinic Acid and Chrysin against Ischemia-Reperfusion Injury in Rat Ovaries
por: Melekoglu, Rauf, et al.
Publicado: (2018)

Effect of the intermittent Pringle maneuver on liver damage after hepatectomy: a retrospective cohort study
por: Wei, Xiaolin, et al.
Publicado: (2019)

Transcriptional profile changes after treatment of ischemia reperfusion injury-induced kidney fibrosis with 18β-glycyrrhetinic acid
por: Jiang, Yamei, et al.
Publicado: (2022)

Inhibition of Myocardial Ischemia/Reperfusion Injury by Exosomes Secreted from Mesenchymal Stem Cells
por: Zhang, Heng, et al.
Publicado: (2016)

Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma
por: Gong, Xun, et al.
Publicado: (2022)

Therapeutic Properties of Mesenchymal Stem Cell on Organ Ischemia-Reperfusion Injury
por: Oliva, Joan
Publicado: (2019)

Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis
por: Li, Jie, et al.
Publicado: (2018)

Exosomes Derived from Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Inhibiting Pyroptosis
por: Tang, Jiayou, et al.
Publicado: (2020)

Exosomes in Cerebral Ischemia-Reperfusion Injury: Current Perspectives and Future Challenges
por: Zhou, Chao, et al.
Publicado: (2022)

Mesenchymal Stem Cells-Derived Exosomes Ameliorate Ischemia/Reperfusion Induced Acute Kidney Injury in a Porcine Model
por: Huang, Jianni, et al.
Publicado: (2022)

Intraperitoneal Administration of Apigenin in Liver Ischemia/Reperfusion Injury Protective Effects
por: Tsaroucha, Alexandra K., et al.
Publicado: (2016)

A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide
por: Zuo, Jiawei, et al.
Publicado: (2023)

CCR2 Positive Exosome Released by Mesenchymal Stem Cells Suppresses Macrophage Functions and Alleviates Ischemia/Reperfusion-Induced Renal Injury
por: Shen, Bing, et al.
Publicado: (2016)

Alleviation of renal ischemia/reperfusion injury by exosomes from induced pluripotent stem cell-derived mesenchymal stem cells
por: Lim, Sun Woo, et al.
Publicado: (2022)

Cell Death and Exosomes Regulation After Myocardial Infarction and Ischemia-Reperfusion
por: Wu, Xun, et al.
Publicado: (2021)

SerpinB3 administration protects liver against ischemia-reperfusion injury
por: Turato, Cristian, et al.
Publicado: (2022)

In vitro and in vivo protein release and anti-ischemia/reperfusion injury properties of bone morphogenetic protein-2-loaded glycyrrhetinic acid-poly(ethylene glycol)-b-poly(l-lysine) nanoparticles
por: Shan, Fang, et al.
Publicado: (2017)

Mesenchymal stromal cells in renal ischemia/reperfusion injury
por: de Vries, Dorottya K., et al.
Publicado: (2012)

Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
por: Rowart, Pascal, et al.
Publicado: (2015)

Maximum Efficacy of Mesenchymal Stem Cells in Rat Model of Renal Ischemia-Reperfusion Injury: Renal Artery Administration with Optimal Numbers
por: Cai, Jieru, et al.
Publicado: (2014)

Enhancement of the Bioavailability and Anti-Inflammatory Activity of Glycyrrhetinic Acid via Novel Soluplus(®)—A Glycyrrhetinic Acid Solid Dispersion
por: Wang, Hao, et al.
Publicado: (2022)

Attenuation of ischemia–reperfusion injury by intracoronary chelating agent administration
por: Han, Donghoon, et al.
Publicado: (2022)

Fyn Signaling in Ischemia-Reperfusion Injury: Potential and Therapeutic Implications
por: Du, Fang, et al.
Publicado: (2022)

Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis
por: Liu, Xiangde, et al.
Publicado: (2016)

Antitumor Effects of Curcumin and Glycyrrhetinic Acid-Modified Curcumin-Loaded Cationic Liposome by Intratumoral Administration
por: Chang, Mingxiang, et al.
Publicado: (2020)

Therapeutic effects of mesenchymal stem cells on renal ischemia–reperfusion injury: a matter of genetic transfer?
por: Bruno, Stefania, et al.
Publicado: (2013)

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Alleviate Ischemia-Reperfusion Injury and Promote Survival of Skin Flaps in Rats
por: Niu, Qifang, et al.
Publicado: (2022)

Mesenchymal Stem Cell-Derived Exosomal Noncoding RNAs as Alternative Treatments for Myocardial Ischemia-Reperfusion Injury: Current Status and Future Perspectives
por: Chang, Chen, et al.
Publicado: (2023)

Preparation of docetaxel-loaded, glycyrrhetinic acid-modified nanoparticles and their liver-targeting and antitumor activity
por: Xue, Hantao, et al.
Publicado: (2021)

Mitochondria as a therapeutic target for cardiac ischemia-reperfusion injury (Review)
por: Marin, Wenwen, et al.
Publicado: (2021)

Pre-Administration of Blackberry Extracts in Induced Ischemia Reperfusion Events in Rodents
por: Oda, Asahi, et al.
Publicado: (2023)

Therapeutic strategies for ischemia reperfusion injury in emergency medicine
por: Naito, Hiromichi, et al.
Publicado: (2020)

Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury
por: Fernandez Rico, Carlota, et al.
Publicado: (2022)

Microvascular Leakage as Therapeutic Target for Ischemia and Reperfusion Injury
por: Kloka, Jan Andreas, et al.
Publicado: (2023)

Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies
por: Jurcau, Anamaria, et al.
Publicado: (2021)

Cardiac fibroblasts secrete exosome microRNA to suppress cardiomyocyte pyroptosis in myocardial ischemia/reperfusion injury
por: Liu, Niannian, et al.
Publicado: (2022)

Atorvastatin treatment attenuates renal injury in an experimental model of ischemia–reperfusion in rats
por: Wu, Kefei, et al.
Publicado: (2014)

Therapeutic Effect and Mechanism of Cinnamyl Alcohol on Myocardial Ischemia-Reperfusion Injury
por: Zhang, Hua, et al.
Publicado: (2022)

Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury
por: Pan, Yihang, et al.
Publicado: (2022)

Prostaglandin E1 Preconditioning Attenuates Liver Ischemia Reperfusion Injury in a Rat Model of Extrahepatic Cholestasis
por: Xu, Feng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rq5aldmtfe3bl2iqts93d0vu4k